Halozyme Therapeutics
HALO
#2069
Rank
C$10.05 B
Marketcap
$81.43
Share price
-0.05%
Change (1 day)
55.52%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): C$0.77 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$1.01 Billion. , an increase over its 2023 earnings that were of C$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 C$0.77 B59.94%
2023 C$0.48 B39.94%
2022 C$0.34 B0.16%
2021 C$0.34 B92.2%
2020 C$0.17 B-278.96%
2019 -C$0.11 Billion-9.45%
2018 -C$0.12 Billion-229.51%
2017 C$85.33 M-160.48%
2016 -C$0.15 Billion216.03%
2015 -C$44.65 Million-52.86%
2014 -C$94.71 Million-18.09%
2013 -C$0.12 Billion55.88%
2012 -C$74.18 Million169.94%
2011 -C$27.48 Million-63.44%
2010 -C$75.16 Million-7.19%
2009 -C$80.98 Million15.91%
2008 -C$69.86 Million83.89%
2007 -C$38 Million78.1%
2006 -C$21.34 Million16%
2005 -C$18.39 Million45.24%
2004 -C$12.67 Million682.42%
2003 -C$1.62 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$42.27 M-94.52%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.56 B 2,176.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.83 Billion-206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.39 B 1,894.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.00 B 1,325.52%๐Ÿ‡ซ๐Ÿ‡ท France
C$24.15 B 3,030.68%๐Ÿ‡บ๐Ÿ‡ธ USA